Mike Polark
Stock Analyst at Baird
(3.53)
# 908
Out of 5,116 analysts
79
Total ratings
50.91%
Success rate
6.62%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $125 → $180 | $95.47 | +88.54% | 9 | Dec 4, 2025 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $86.85 | - | 5 | Oct 29, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $180 → $220 | $176.60 | +24.58% | 9 | Oct 10, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $96.52 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $31.86 | -37.23% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $62.87 | -4.56% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $288.63 | +21.26% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $27.15 | +6.81% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $244.76 | -26.46% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $90.77 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $354.22 | +14.34% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $577.81 | -12.95% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $124.84 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $122.76 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $67.57 | +79.07% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $22.35 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $17.70 | +41.24% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $132.76 | +24.28% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $96.06 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.02 | -18.85% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.47 | +369.80% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $255.42 | -2.12% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.44 | +1,662.30% | 1 | Sep 2, 2020 |
Inspire Medical Systems
Dec 4, 2025
Maintains: Outperform
Price Target: $125 → $180
Current: $95.47
Upside: +88.54%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $86.85
Upside: -
iRhythm Technologies
Oct 10, 2025
Maintains: Outperform
Price Target: $180 → $220
Current: $176.60
Upside: +24.58%
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $96.52
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $31.86
Upside: -37.23%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $62.87
Upside: -4.56%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $288.63
Upside: +21.26%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $27.15
Upside: +6.81%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $244.76
Upside: -26.46%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $90.77
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $354.22
Upside: +14.34%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $577.81
Upside: -12.95%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $124.84
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $122.76
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $67.57
Upside: +79.07%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $22.35
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $17.70
Upside: +41.24%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $132.76
Upside: +24.28%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $96.06
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $16.02
Upside: -18.85%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.47
Upside: +369.80%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $255.42
Upside: -2.12%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.44
Upside: +1,662.30%